Feedback
Beryllium Quantitative, Serum or Plasma
3000967
Ordering Recommendation

Confirm an exposure to beryllium but NOT useful indicator for determining time since exposure or the extent of an exposure. Refer to Beryllium Lymphocyte Proliferation, Blood (2011052) for a more reliable indicator of beryllium sensitization and/or chronic beryllium disease (CBD).

Mnemonic
BERYLLI SP
Methodology
Quantitative Inductively Coupled Plasma-Mass Spectrometry
Performed
Varies
Reported
3-8 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Royal Blue (no additive) or Royal Blue (EDTA). 
Specimen Preparation
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an Acid Washed Transport Vial (ARUP supply #54350) available online through eSupply using ARUP Connect or contact ARUP Client Services at (800) 522-2787. (Min: 0.4 mL) 
Storage/Transport Temperature
Refrigerated. Also acceptable: Room temperature or frozen. 
Unacceptable Conditions
Separator tubes. 
Remarks
 
Stability
Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 2 weeks 
Reference Interval
By report
Interpretive Data


Note
Hotline History
View Hotline History
Components
Component Test Code*Component Chart NameLOINC
3000968Beryllium Quantitative, Serum/Plasma5594-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Be

Performed at National Medical Services (NMS)